Macrohemodynamic Impact of Fluid Removal With Net Ultrafiltration in Patients With Continuous Renal Replacement Therapy
Sponsored by Hospices Civils de Lyon
About this trial
Last updated a year ago
Study ID
Status
Type
Placebo
Accepting
Not accepting
Trial Timing
Started a year ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Acute kidney injury treated by continuous renal replacement therapy in ICU less than 7 days,
- At least 1 organ failure during ICU in addition to AKI (mechanical ventilation or vasopressors administration>12 hours),
- Cumulative UF net less than 1000ml before inclusion,
- Norepinephrine < 0,5 µg/kg/min,
- Absence of hypoperfusion signs,
- Fluid overload defined as follows: fluid overload > 5% of base weight (based on cumulative fluid balance or a weight gain) and/or peripheral edema (AKIKI edema scale > 2).
Exclusion Criteria
- Chronic renal failure hemodialyzed before admission to the ICU,
- Mechanical circulatory support (ECMO, LVAD),
- Pregnant, child -bearing age or lactating women,
- Stroke less than 30 days,
- Intestinal ischemia less than 7 days documented non-operated,
- Interventional study participation or exclusion period on going,
- Guardianship, curatorship or safeguard of justice,
- Absence of signature of free and informed consent by the patient and/or relative,
- Patients not affiliated to a social security scheme or beneficiaries of a similar scheme
- Absence of transpulmonary thermodilution monitoring